BUFDX
Price
$33.26
Change
+$0.21 (+0.64%)
Updated
Jan 17 closing price
Net Assets
169.9M
VFIAX
Price
$553.67
Change
+$5.49 (+1.00%)
Updated
Jan 17 closing price
Net Assets
1.35T
Ad is loading...

BUFDX vs VFIAX

Header iconBUFDX vs VFIAX Comparison
Open Charts BUFDX vs VFIAXBanner chart's image
Buffalo Growth & Income
Price$33.26
Change+$0.21 (+0.64%)
VolumeN/A
Net Assets169.9M
Vanguard 500 Index Admiral
Price$553.67
Change+$5.49 (+1.00%)
VolumeN/A
Net Assets1.35T
BUFDX vs VFIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BUFDX vs. VFIAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUFDX is a StrongBuy and VFIAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.35T vs. BUFDX (170M). BUFDX (1.35) and VFIAX (1.32) have matching dividends . BUFDX was incepted earlier than VFIAX: BUFDX (12 years) vs VFIAX (24 years). BUFDX (2.00) and VFIAX (2.00) have comparable annual turnover. BUFDX has a lower initial minimum investment than VFIAX: BUFDX (2500) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 25.54 vs. BUFDX (23.67). VFIAX (80.23) and BUFDX (77.57) have equivalent 5 years return.
BUFDXVFIAXBUFDX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years24 years-
Gain YTD2.4962.010124%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets170M1.35T0%
Annual Yield % from dividends1.351.32102%
Returns for 1 year23.6725.5493%
Returns for 3 years32.8331.13105%
Returns for 5 years77.5780.2397%
Returns for 10 years171.55196.9887%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.790.45
+7.10%
LexinFintech Holdings Ltd
GATX154.690.58
+0.38%
GATX Corp
ALC84.370.23
+0.27%
Alcon
ANTX1.27N/A
N/A
AN2 Therapeutics
NMM42.48-1.07
-2.46%
Navios Maritime Partners LP